64839-09-4

Basic information

• Product Name: 3-(Benzyloxy)-2-methylpropan-1-ol
• Synonyms: 3-Benzyloxy-2-methylpropan-1-ol
• CAS NO: 64839-09-4
• Molecular Formula: C₁₁H₁₆O₂
• Molecular Weight: 180.25
• Mol File: 64839-09-4.mol
• Article Data: 23

Chemical Properties

• Appearance: /
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: 3-(Benzyloxy)-2-methylpropan-1-ol(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(Benzyloxy)-2-methylpropan-1-ol(64839-09-4)
• EPA Substance Registry System: 3-(Benzyloxy)-2-methylpropan-1-ol(64839-09-4)

Safety Data

• Hazardous Substances Data: 64839-09-4(Hazardous Substances Data)

Upstream product

• 5658-46-8 ((2-methylallyloxy)methyl)benzene 
• 91796-44-0 Benzyl 3-(phenylmethoxy)-2-methylpropanoate 
• 2163-42-0 2-methyl-1.3-propanediol 
• 100-39-0 benzyl bromide 
• 124755-27-7 (E)-(2R,5R,6S)-7-<(tert-butyldimethylsilyl)oxy>-2,4,6-trimethyl-3-heptene-1,5-diol 
• 139017-28-0 1-(3-Benzyloxy-2-methyl-propyl)-1-phenyl-silolane 
• 126308-98-3 4-(3-Benzyloxy-2-methyl-propoxymethyl)-1,2-dimethoxy-benzene 
• 126309-00-0 4-(3-Benzyloxy-2-methyl-propoxymethyl)-1,5-dimethoxy-naphthalene 
• 3587-60-8 Benzyloxymethyl chloride 
• 191105-59-6 (S)-N-propionyl-4-(4-hydroxybenzyl)oxazolidin-2-one 
• 27942-89-8 5-methyl-2-phenyl-[1,3]dioxane 
• 100-52-7 benzaldehyde 
• 59965-24-1 (+/-)-methyl 2-methyl-3-(phenylmethoxy)propanoate 

Downstream Products

• 63930-49-4 (R)-3-(benzyloxy)-2-methylpropan-1-ol 
• 63930-46-1 (S)-3-benzyloxy-2-methylpropan-1-ol 
• 141885-91-8 (S)-3-benzyloxy-2-methylpropyl acetate 
• 141885-91-8 (R)-3-benzyloxy-2-methylpropyl acetate 
• 64316-89-8 (S)-3,3,3-Trifluoro-2-methoxy-2-phenyl-propionic acid 3-benzyloxy-2-methyl-propyl ester 
• 74130-31-7 3-(benzyloxy)-2-methylpropanal 
• 96556-45-5 3-(benzyloxy)-2-methylpropyl p-toluenesulfonate 
• 16897-88-4 (2RS,3SR)-4-benzyloxy-3-methyl-2-butanol 
• 64809-18-3 4-benzyloxy-3-methylbutyronitrile 
• 80160-75-4 (5S,6S)-6-((R)-2-Benzyloxy-1-methyl-ethyl)-5-methyl-4-pyrrolidin-1-yl-5,6-dihydro-pyran-2-one 
• 80160-75-4 (5S,6S)-6-((S)-2-Benzyloxy-1-methyl-ethyl)-5-methyl-4-pyrrolidin-1-yl-5,6-dihydro-pyran-2-one 
• 64316-89-8 (S)-3,3,3-Trifluoro-2-methoxy-2-phenyl-propionic acid (R)-3-benzyloxy-2-methyl-propyl ester 
• 64316-89-8 (S)-3,3,3-Trifluoro-2-methoxy-2-phenyl-propionic acid (S)-3-benzyloxy-2-methyl-propyl ester 
• 87702-54-3 (S)-3-((2R,3S)-5-Benzyloxy-3-hydroxy-2,4-dimethyl-pentanoyl)-4-isopropyl-oxazolidin-2-one 

Relevant articles and documents

6-HETEROARYLOXY BENZIMIDAZOLES AND AZABENZIMIDAZOLES AS JAK2 INHIBITORS

The present disclosure provides 6-heteroaryloxy benzimidazole and azabenzimidazole compounds and compositions thereof useful for inhibiting JAK2.

Substituted heteroaryl compound and composition thereof, and uses of substituted heteroaryl compound and composition thereof

The present invention provides a substituted heteroaryl compound and a composition thereof, and uses of the substituted heteroaryl compound and the composition, wherein the compound is a compound represented by a formula (I) or a stereoisomer, a tautomer, a nitrogen oxide, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug of the compound represented by the formula (I). The present invention further provides a pharmaceutical composition containing the compound, wherein the pharmaceutical composition can regulate activity of protein kinases, particularly Aurora kinases and JAK kinases, and can be used for prevention, treatment, therapy and alleviation of protein kinases, particularly Aurora kinases and JAK kinase activity mediated diseases or disorders.

N-SUBSTITUTED PIPERIDINE DERIVATIVES AS SEROTONIN RECEPTOR AGENTS

Disclosed herein are substantially pure forms of the compounds of Formula (I), (II), (III), (IV) and (V), or a pharmaceutically acceptable salt, prodrug, hydrate, solvate, polymorph, stereoisomer or ester thereof. Also disclosed are methods of inhibiting an activity of a serotonin receptor, methods inhibiting an activation of a serotonin receptor, and methods of alleviating or treating various disease conditions and side effects.